Author

G. Bou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Ambroa· 1 shared A. Beceiro· 1 shared A. Croxatto· 1 shared A. Ingebretsen· 1 shared A. K. Steffensen· 1 shared A. Oliver· 1 shared A. Pascual· 1 shared B. Rodriguez-Sanchez· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ambroa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evaluation of the rapidBACpro(R) II kit for the rapid identification of microorganisms directly from blood cultures using MALDI-TOF MS

M. Oviano, A. Ingebretsen, A. K. Steffensen, A. Croxatto, G. Prod'hom, L. Quiroga, G. Bou, G. Greub, B. Rodriguez-Sanchez

This study evaluates the rapidBACpro(R) II kit for identifying microorganisms from blood cultures using MALDI-TOF MS, finding high species-level accuracy, especially for Gram-positive bacteria.

bioRxiv · Jan 25, 2021 · PreprintMicrobiology

In vitro and in vivo efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogens

L. Blasco, A. Ambroa, R. Trastoy, E. Perez-Nadales, F. Fernandez-Cuenca, J. Torre-Cisneros, J. Oteo-Iglesias, A. Oliver, R. Canton, T. J. Kidd, F. Navarro, E. Miro, A. Pascual, G. Bou, L. Martinez-Martinez, M. Tomas

This study evaluates the in vitro and in vivo efficacy of combining colistin with endolysins ElyA1 and ElyA2 against MDR pathogens, finding that ElyA1 enhances colistin's antimicrobial activity and reduces its MIC.

Scientific Reports · Apr 28, 2020Peer-reviewedMicrobiology

Implication of HisF from Acinetobacter baumannii in persistence during a pneumonia infection

M. Martinez-Guitian, J. C. Vazquez-Ucha, L. Alvarez-Fraga, K. Conde-Perez, J. A. Vallejo, G. Bou, M. Poza, A. Beceiro

This study identifies HisF from A. baumannii as a negative regulator of pro-inflammatory cytokine production during pneumonia, suggesting it as a potential antimicrobial target.

bioRxiv · Jan 31, 2019 · PreprintMicrobiology